http://observatoiredelacensure.over-blog.com/ext/http://mediator150mg.blogspot.com/
June 16, 2010: Pharmaceutical company Servier cons editions Dialogues and Dr. Frachon (Brest)
On November 30, 2009, following a decision by the French Agency for the Safety of Products health ( AFSSAPS) , benfluorex containing three drugs, including the Mediator 150 mg were removed from pharmacies because of their "modest efficacy" on diabetes type 2, and "proven risks of heart valve damage. If two drugs were generics recently put on the market (early October 2009) by Mylan Laboratories QUALIMED and it was different for Mediator 150mg marketed by Servier Laboratories since 1976 . 200 to 300,000 people consumed each day. Majority were women, using it as an appetite suppressant to lose weight. 2000000 people would have consumed since its introduction in the market. Turnover of 150 mg Mediator for Servier was approximately $ 3.6 million per year. The medical journal Prescrire welcomed the withdrawal of this "amphetamine" , banned from the market "for years in Spain." His "adverse cardiovascular and neuropsychiatric are superimposable to those that led to the recall of two other anorectic amphetamine: fenfluramine (former weight) and dexfenfluramine (ex Isomeride)" . In
150 Picks mg, how many deaths? published June 2, 2010 by editor Charles Kermarec Brest, also director of the library Dialogues, Dr. Irene Frachon, pulmonologist at the University Hospital of Brest, a specialist in pulmonary arterial hypertension (PAH) is back in the form of a newspaper, on every stage of a three-year investigation that led to become one of the protagonists behind the withdrawal of the drug. His testimony of the Interior begins with a scene autopsy, that of Mrs. A., who had taken the diet drug ... For Rony Brauman, this testimony "exemplary" raises many questions marketing practices of pharmaceutical companies. What are their influence and involvement in public health decisions, writes in the afterword former president of Doctors Without Borders ? What is the independence of devices for assessing medication on time "which reduces the public funding of pharmacovigilance activities assigned in increasing proportions of drug companies' when " Most clinical trials of new drugs, published under the signature of academic physicians (...) are actually written by Negroes Industry pharmaceutical.
Is the independence of the author of the book, and their publishers postfacier Breton which did not please the powerful group Servier, when the Nanterre court authorized the appointment of an expert to examine the case of a patient suffering from a serious heart condition and had fallen Mediator three times daily for seven years? The fact is that the pharmaceutical group has responded by attacking the book justice. No on its content on its packaging, its title. On 7 June, the judge in Brest said that the word " How many deaths?" threw the "discredited" image Servier Laboratory , "impeding its activity" , infringed his rights and should be removed from the front cover with a penalty of 50 euros per copy distributed. For the judge, "a return market Mediator is always possible" . In this case, "denigration caused by the words would prove highly contentious source of discredit" .
To the editor who fired to 5,500 copies, the book is a "de facto ban" . He appealed and, pending trial, has been making stickers to place on each copy of the censored words. In addition, he has decided to reprint the book. It is available with a new cover ISBN amended stating Mediator 150mg, Subtitle censored, in digital and hard copy.
0 comments:
Post a Comment